Journal of Diabetes Research / 2019 / Article / Tab 1

Research Article

The Association between Metabolic Syndrome and Morbid Events in Type 2 Diabetes after a 7-Year Community Management: Beijing Community Diabetes Study 17

Table 1

Baseline clinical characteristics in different groups.

VariableNon-MS groupMS group
()()

Age (year)0.336
Gender ( (%))
 Male473 (57.89)942 (34.79)<0.001
 Female344 (42.11)1766 (65.21)
Educational attainment ( (%))<0.001
 Illiteracy or elementary school102 (12.52)522 (19.44)
 Middle school511 (62.70)1616 (60.19)
 College or academic degree202 (24.79)547 (20.37)
Diabetic duration (year)4.0 (0.3, 9.3)3.8 (0.0, 9.1)0.227
Body mass index (kg/m2)<0.001
Waist circumference (cm)<0.001
Neck circumference (cm)<0.001
Systolic blood pressure (mmHg)<0.001
Diastolic blood pressure (mmHg)<0.001
Fasting plasma glucose (mmol/l)0.009
Postprandial glucose (mmol/l)0.011
Hemoglobin A1c (%)<0.001
Hemoglobin A1c (mmol/mol)<0.001
Triglyceride (mmol/l)<0.001
Total cholesterol (mmol/l)0.03
High-density lipoprotein cholesterol (mmol/l)<0.001
Low-density lipoprotein cholesterol (mmol/l)0.049
Uric acid (μmol/l)260 (209, 324)289 (232, 348)<0.001
Urinary albumin excretion rate (μg/min)6.6 (4.5, 12.2)8.3 (5.2, 19.0)<0.001
Smoking ( (%))139 (17.01)403 (14.88)0.139
Antihypertension medication ( (%))316 (38.68)1836 (67.80)<0.001
Antihyperglycemic medication ( (%))753 (92.17)2475 (91.40)0.487
 Metformin ( (%))247 (30.23)694 (25.63)0.009
 Sulfonylurea ( (%))327 (40.02)1270 (46.90)0.001
 Insulin ( (%))166 (20.32)595 (21.97)0.314
Statin ( (%))126 (15.42)607 (22.42)<0.001

Values are expressed as , numbers (%), or median (range). Diabetic duration, uric acid, and urinary albumin excretion rate: median (range); the nonparametric test was used. MS: metabolic syndrome.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.